SEARCH

SEARCH BY CITATION

Reference

  • 1
    Seaberg EC, Belle SH, Beringer K, Schlaak JF, Schivins JL, Detre KM. Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry. In: CeckaJM, TerasakiPI, eds. Clinical transplants 1998, 1st ed. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 1737.
  • 2
    Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation [Comments]. N Engl J Med 1996; 334: 815820.
  • 3
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998; 28: 823830.
  • 4
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250256.
  • 5
    Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997; 64: 422426.
  • 6
    Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 11371143.
  • 7
    Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JY, Simmonds P, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 10411046.
  • 8
    Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671675.
  • 9
    Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation [Comments]. Gastroenterology 2002; 122: 889896.
  • 10
    Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994; 20: 24S27S.
  • 11
    Prieto M, Berenguer M, Rimola A, Loinaz C, Barrios C, Clemente G, et al. Liver transplantation in hepatitis C. A Spanish multi-centre experience. Eur J Gastroenterol Hepatol 1998; 10: 771776.
  • 12
    O'Reilly PM, Rosen HR, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, Martin P. Causes of graft loss following liver transplantation for chronic hepatitis C. Transplant Proc 1997; 29: 526528.
  • 13
    Detre KM, Belle SH, Lombardero M. Liver transplantation for chronic viral hepatitis. Viral Hepatitis Review 1996; 2: 219228.
  • 14
    Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: clinical and virological features. Hepatology 1995; 22: 19.
  • 15
    Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317322.
  • 16
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease [Comments]. Hepatology 2001; 33: 464470.
  • 17
    Wei YW, Detre KM, Everhart JE. The NIDDK Liver Transplantation Database. Liver Transpl Surg 1997; 3: 1022.
  • 18
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes [Letter]. Hepatology 1994; 19: 13211324.
  • 19
    Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB, Jr, et al. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation. Transplantation 1997; 63: 14191423.
  • 20
    Brieman L, Freidman JH, Olshen RA, Stone CJ. Classification in regression trees, 1st ed. Belmont, CA: Wadsworth Inc., 1984. pp. 17.
  • 21
    Cox DR. Regression models and life tables. J Royal Stat Soc 1997; 34: 187220.
  • 22
    Charlton M. Patient and graft survival following liver transplantation for hepatitis C: much ado about something [Letter; Comment]. Gastroenterology 2002; 122: 11621165.
  • 23
    Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673684.
  • 24
    Crippin JS, McCashland TM, Terrault NA, Sheiner PA, Charlton MR. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation. Liver Transplantation 2002; 8: 350355.
  • 25
    Heathcote J, Shiffman ML, Cooksley GW, Dusheiko G, Lee SS, Balart L, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Eng J Med 2000; 343: 16731679.
  • 26
    Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart, et al. Donor age and outcome of liver transplantation. Hepatology 1996; 24: 8996.
  • 27
    Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001; 72: 11131122.
  • 28
    Busquets J, Xiol X, Figueras J, Jaurrieta E, Torras J, Ramos E, et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001; 71: 17651771.
  • 29
    Sieders E, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Zwaveling JH, et al. Prognostic factors for long-term actual patient survival after orthotopic liver transplantation in children. Transplantation 2000; 70: 14481453.
  • 30
    Burak K, Kremers W, Batts KP, Wiesner RH, Rosen CB, Razonable R, et al. The impact of cytomegalovirus infection in patients undergoing liver transplantation for hepatitis C. Liver Transpl 2002; 8: 362369.
  • 31
    Pirenne J, Declauwe H, Aerts R, Van Gelder F, Van Steenbergen W, Verslype C, et al. Patients transplanted for hepatitis C should not receive organs from older donors. Hepatology 2001; 34: 409A.
  • 32
    Deschenes M, Forbes C, Tchervenkov J, Barkun J, Metrakos P, Tector J, Alpert E. Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation [Comments]. Liver Transpl Surg 1999; 5: 357361.
  • 33
    Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, et al. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 2001; 34: 283287.
  • 34
    Lazzarotto T, Paya CV, Smith TF, Wiesner RH, Krom R, Landini MP. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis. Microbiologica 1992; 15: 1522.
  • 35
    Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RA, Paya CV. Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation [Review]. Gastroenterol Clin North Am 1993; 22: 351366.
  • 36
    Langnas AN, Marujo WC, Inagaki M, Stratta RJ, Wood RP, Shaw BW, Jr. The results of reduced-size liver transplantation, including split livers, in patients with end-stage liver disease. Transplantation 1992; 53: 387391.
  • 37
    Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997; 64: 721726.
  • 38
    Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis [Comments] [published erratum appears in Ann Intern Med 1997 Oct 15;127(8 Pt 1):658]. Ann Intern Med 1997; 126: 137145.
  • 39
    Stratta RJ, Shaefer MS, Markin RS, Wood RP, Kennedy EM, Langnas AN, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 14431449.
  • 40
    Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, et al. The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis 2002; 35: 974981.
  • 41
    Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner MW, Hoots WK, et al. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 2001; 26: 466472.
  • 42
    Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, et al. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001; 183: 589595.
  • 43
    Boker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25: 203210.
  • 44
    Barcena R, Del Campo S, Sanroman AL, Nuno J, Zelaya R, Honrubia A, et al. Prospective study of hepatitis C virus infection after orthotopic liver transplantation. Transplant Proc 1997; 29: 515516.
  • 45
    Zein N, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing D. HCV genotypes in liver transplant recipients: distribution and one year follow-up. Liver Transpl Surg 1995; 1: 335357.
  • 46
    Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61: 402406.